CDKN2A and lung carcinoma: Interestingly, expression and activation of Dmp1:ER in the ARF+P53 wild-type lung cancer cell line strongly inhibited the growth of the cells, while other lung cancer cells with deletion of ARF or P53 were relatively resistant (Mallakin et al. 2007).